Novo Nordisk And Shanghai Institute For Biological Sciences Jointly Set Up Research Center For Pre-diabetes
This article was originally published in PharmAsia News
Executive Summary
Novo Nordisk and Chinese Academy of Science's Shanghai Institute for Biological Sciences recently inaugurated a research center for pre-diabetes in Shanghai. China's first such facility, the joint venture will bring diabetes prevention to the pre-development stage of the disease. The center will initiate early monitoring and intervention in individuals who are at high risk of developing diabetes during the pre-clinical reversible stage. Individuals' samples and data will be collected during clinics and community follow-up. The research will focus on molecular mechanism and markers in the development of obesity and diabetes, as well as explore nutritional intervention methods and lifestyle changes to slow the disease. (Click here for more - Chinese Language)